Acadian Asset Management’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Acadian Asset Management’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,274	Closed	-$42K	–	2276
2024 Q3	$42K	Buy	+1,274	New	+$43.9K	﹤0.01%	1852

Acadian Asset Management's LBPH Position: Q4 2024 in Review

Acadian Asset Management sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 1,274 shares — an estimated $42K sold.

Acadian Asset Management first reported a position in LBPH in Q3 2024 and held it in 1 quarter. The position peaked at $42K in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Acadian Asset Management reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Acadian Asset Management sold 1,274 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $42K.
Acadian Asset Management first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q3 2024 and held it in 1 quarter.
Acadian Asset Management's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $42K in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Acadian Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.